The Quantellect read.As of Nov 19, 2026, 17 active firms cover Emerson Electric Company: 9 rate it Buy or better, 7 sit at Neutral, and 1 rate it Sell or worse, a neutral consensus. Targets are tightly clustered, $144.00 to $190.00, so the covering firms are broadly aligned. The average target of $169.94 sits 5% above the current $161.73. The rating mix has stayed broadly stable, with Buy-side ratings edging up from 7 to 9 over recent months. On the fundamentals, the Street sees consensus EPS building from about $1.73 next quarter toward $8.03 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS17 active firms
Neutral
Strong Buy00%
Buy953%
Neutral741%
Sell16%
Strong Sell00%
Based on 17 active firms as of Nov 19, 2026 (365-day activity window).
12-MONTH PRICE TARGET
$169.94
+5.1% upside
Average target across 16 active firms as of Nov 19, 2026 vs $161.73 current
Highest Target$190.00
Average Target$169.94
Lowest Target$144.00
Detailed analyst forecasts for EMR
Showing 1–20 of 20 named analysts shown · 17 active firms in the rating projection
As of Nov 19, 2026, 9 of 17 active firms rate EMR a Buy (7 Neutral, 1 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
EMR EPS & revenue forecast
EPS · NEXT QUARTER
$1.73
Range $1.67 – $1.83 · 21 analysts · +13% YoY
Next period, 21 analysts expect Emerson Electric Company to earn $1.73 a share (range $1.67 – $1.83), versus $1.54 a year earlier. Full-year consensus is $7.31, growing to $8.03 the year after.
REVENUE · NEXT QUARTER
$4.9B
Range $4.8B – $4.9B · 21 analysts · +6% YoY
Revenue is expected to reach $4.9B (range $4.8B – $4.9B), +6.3% year-over-year. Full-year consensus is $20.0B, rising to $21.1B next year.
Top analysts covering Emerson Electric Company
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on EMR.
#1
Stephen Tusa
JP Morgan · Rank #8
Neutral
$157.00-2.9% to target
Overall win rate
55%
+ Follow
#2
Christopher Glynn
Oppenheimer · Rank #45
Neutral
No targeton EMR
Overall win rate
52%
+ Follow
#3
Tommy Moll
Stephens & Co. · Rank #93
Neutral
$155.00-4.2% to target
Overall win rate
47%
+ Follow
#4
Julian Mitchell
Barclays · Rank #281
Neutral
$144.00-11.0% to target
Overall win rate
40%
+ Follow
#5
Deane Dray
RBC Capital · Rank #329
Buy
$179.00+10.7% to target
Overall win rate
43%
+ Follow
EMR stock forecast FAQ
What is EMR's average 12-month price target?+
The 16 active firms with a live target average $169.94 for Emerson Electric Company over the next 12 months, ranging from a $190.00 high to a $144.00 low, as of Nov 19, 2026.
Is EMR stock a Buy, Sell or Neutral right now?+
The current consensus is Neutral. Of the 17 active firms as of Nov 19, 2026, 9 rate it Buy or Strong Buy, 7 rate it Neutral, and 1 rate it Sell or Strong Sell.
What are the highest and lowest price targets for EMR?+
The Street-high target is $190.00 (Evercore ISI Group), and the Street-low is $144.00 (Barclays). The average of all 16 active-firm targets is $169.94.
How many active Wall Street firms cover EMR?+
17 active firms have a recognized rating on Emerson Electric Company as of Nov 19, 2026, and 16 active firms carry a live 12-month price target.
Who is the most accurate analyst covering EMR?+
Among analysts who currently cover EMR, Stephen Tusa of JP Morgan has the strongest overall Quantellect track record (Rank #8). Their current call is Neutral with a $157.00 target.
What is Emerson Electric Company's projected EPS for next quarter?+
The consensus estimate is $1.73 per share (range $1.67 – $1.83) across 21 analysts. Full-year EPS is projected at $7.31, rising to $8.03 the following year.
How much revenue is Emerson Electric Company expected to report next quarter?+
Consensus revenue is $4.9B (range $4.8B – $4.9B). Full-year revenue is projected at $20.0B, growing to $21.1B next year.
Have analysts been upgrading or downgrading EMR lately?+
As of Nov 19, 2026, 9 of 17 active firms rate EMR a Buy (7 Neutral, 1 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their EMR calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.